Treatment of Venous Thromboembolism (VTE)
Geschreven op 07.12.2009Phase III EINSTEIN-Extension Study of Bayer's Rivaroxaban Shows Significant Benefit in the Prevention of Secondary Symptomatic VTE
Lees meer over de EINSTEIN studieresultaten: http://www.baynews.bayer.de/baynews/baynews.nsf/id/AAC65028D1D803FFC125768400494782?open&ccm=000.
« Terug naar overzicht